Evaluation of Ganovo Combined With Ritonavir in the Treatment of Novel Coronavirus Infection
Condition: 2019-nCoV Pneumonia Interventions: Drug: Ganovo+ritonavir with or without interferon atomization; Drug: Pegasys; Drug: Novaferon atomization; Drug: Lopinavir+ritonavir; Drug: Chinese medicines +interferon atomization Sponsors: The Ninth Hospital of Nanchang; Ascletis Pharmaceuticals Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2020 Category: Research Source Type: clinical trials
Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis
Conditions: Hepatitis B; Liver Fibrosis Interventions: Drug: Tenofovir Disoproxil Fumarate; Drug: PEG-Interferon alfa 2a Sponsor: Third Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 21, 2019 Category: Research Source Type: clinical trials
